Syros Pharmaceuticals (SYRS) Stock Chart & Stock Price History $0.02 0.00 (-7.50%) As of 10:10 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Syros Pharmaceuticals Stock Price Performance The Syros Pharmaceuticals (SYRS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.62%, with a year-to-date return of -90.34%. In the past month, the stock has decreased 35.09%, reflecting recent market activity. As of the latest close, Syros Pharmaceuticals traded at $0.02 with a market cap of $644 thousand and volume of 134,344 shares. Five years ago, the stock traded at a split-adjusted price of $91.70, representing a 99.98% decrease over that period. At the time, it had a market cap of $431.80 million and a volume of 271,000 shares. Receive SYRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-12.94%1 Month Performance-35.09%3 Month Performance-70.98%Year-To-Date Performance-90.34%1 Year Performance-99.62%5 Year Performance-99.98% SYRS Stock Chart for Friday, June, 13, 2025 SYRS Chart by TradingView Syros Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$0.02$0.02+1.27%$0.03$0.02134,344 shs$644,000.0006/11/2025$0.03$0.02-5.58%$0.03$0.02317,259 shs$636,000.0006/10/2025$0.03$0.03+0.40%$0.03$0.03128,976 shs$673,000.0006/09/2025$0.03$0.03-1.96%$0.03$0.0349,994 shs$671,000.0006/06/2025$0.03$0.03+2.00%$0.03$0.0361,913 shs$684,000.0006/05/2025$0.03$0.03-0.40%$0.03$0.0249,709 shs$671,000.0006/04/2025$0.03$0.03-3.09%$0.03$0.03102,176 shs$673,000.0006/03/2025$0.03$0.03-19.06%$0.03$0.0396,357 shs$695,000.0006/02/2025$0.03$0.03+18.96%$0.03$0.03167,426 shs$859,000.0005/30/2025$0.03$0.03-12.66%$0.03$0.03149,405 shs$722,000.00 Get the Latest News and Ratings for SYRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$0.03$0.03+12.00%$0.03$0.0372,777 shs$826,000.0005/28/2025$0.03$0.03-0.36%$0.03$0.03100,299 shs$738,000.0005/27/2025$0.03$0.03-11.25%$0.03$0.03382,223 shs$741,000.0005/26/2025$0.03$0.03$0.03$0.03166,889 shs$834,000.0005/23/2025$0.03$0.03+6.87%$0.03$0.03166,889 shs$834,000.0005/22/2025$0.03$0.03-3.32%$0.03$0.0392,135 shs$781,000.0005/21/2025$0.03$0.03+0.67%$0.04$0.03283,426 shs$808,000.0005/20/2025$0.03$0.03-1.32%$0.04$0.03111,275 shs$802,000.0005/19/2025$0.04$0.03-14.16%$0.04$0.0361,130 shs$813,000.0005/16/2025$0.03$0.04+12.06%$0.04$0.0324,526 shs$947,000.0005/15/2025$0.04$0.03-10.26%$0.04$0.0348,591 shs$845,000.0005/14/2025$0.03$0.04+2.63%$0.04$0.0392,607 shs$942,000.0005/13/2025$0.04$0.03-10.47%$0.05$0.03167,561 shs$918,000.0005/12/2025$0.03$0.04+26.07%$0.05$0.03344,118 shs$1.03 million Related Companies SPRC Stock Price Chart GENE Stock Price Chart PWUP Stock Price Chart VIVS Stock Price Chart NBY Stock Price Chart VRAX Stock Price Chart CDT Stock Price Chart ZVSA Stock Price Chart ENVB Stock Price Chart ELAB Stock Price Chart Receive SYRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SYRS) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
